Additional file 6 of Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells

Additional file 6: Supplementary Table 1. List of the 334 genes identified by 103 probes using the most variable 1% of probes differentially methylated between the tumors from mice treated with guadecitabine compared to those without guadecitabine.